Primary hyperparathyroidism: insights from the Indian PHPT registry

• Published in: Journal of bone and mineral metabolism Vol. 36; no. 2; pp. 238 - 245
• Main Authors: Bhadada, Sanjay Kumar, Arya, Ashutosh Kumar, Mukhopadhyay, Satinath, Khadgawat, Rajesh, Sukumar, Suja, Lodha, Sailesh, Singh, Deependra N., Sathya, Anjali, Singh, Priyanka, Bhansali, Anil
• Format: Journal Article
• Language: English
• Published: Tokyo Springer Japan 01.03.2018; Springer Nature B.V
• Subjects: Adenoma; Adult; Asian Continental Ancestry Group; Bone and Bones - pathology; Calcium; Calcium (blood); Demography; Female; Gastrointestinal Tract - pathology; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Primary - blood; Hyperparathyroidism, Primary - pathology; Hyperparathyroidism, Primary - surgery; India; Kidney - pathology; Lithiasis; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Middle Aged; Original Article; Orthopedics; Pain; Pancreatitis; Parathyroid; Parathyroid hormone; Parathyroid Neoplasms - pathology; Parathyroidectomy; Phosphorus; Postoperative Care; Registries; Retrospective Studies; Tumors; Ultrasound; Vitamin D; India; Primary hyperparathyroidism; Multicentre study; Registry; Hypercalcaemia
• DOI: 10.1007/s00774-017-0833-8
• ISSN: 0914-8779; 1435-5604

The presentation of primary hyperparathyroidism (PHPT) is variable throughout the world. The present study explored retrospective data submitted to the Indian PHPT registry ( http://www.indianphptregistry.com ) between July 2005 and June 2015 from 5 centres covering four different geographical regions. The clinical, biochemical, radiological and histopathological characteristics of PHPT patients across India were analysed for similarity and variability across the centres. A total of 464 subjects (137 men and 327 women) with histopathologically proven PHPT were analysed. The mean age was 41 ± 14 years with a female:male ratio of 2.4:1. The majority (95%) of patients were symptomatic. Common clinical manifestations among all the centres were weakness and fatigability (58.7%), bone pain (56%), renal stone disease (31%), pancreatitis (12.3%) and gallstone disease (11%). Mean serum calcium, parathyroid hormone and inorganic phosphorus levels were 11.9 ± 1.6 mg/dL, 752.4 ± 735.2 pg/mL and 2.8 ± 0.9 mg/dL, respectively. Sestamibi scanning had better sensitivity than ultrasonography in the localisation of parathyroid adenoma; however, when these two modalities were combined, 93% of the cases were correctly localised. Mean parathyroid adenoma weight was 5.6 ± 6.5 g (0.1–54 g). It was concluded that the majority of PHPT patients within India are still mainly symptomatic with >50% of patients presenting with bone disease and one-third with renal impairment. Compared to Western countries, Indian patients with PHPT are younger, biochemical abnormalities are more severe, and adenoma weight is higher. As our observation is largely derived from a tertiary care hospital (no routine screening of serum calcium level), the results do not reflect racial differences in susceptibility to PHPT.